ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
10.90
-0.03 (-0.27%)
At close: Apr 28, 2026, 4:00 PM EDT
10.88
-0.02 (-0.18%)
After-hours: Apr 28, 2026, 7:32 PM EDT
ADMA Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,532 | 4,341 | 4,054 | 1,021 | 857 | 276 | |
| Market Cap Growth | -45.07% | 7.08% | 296.93% | 19.17% | 210.44% | 49.75% | |
| Enterprise Value | 2,525 | 4,363 | 4,079 | 1,100 | 975 | 343 | |
| Last Close Price | 10.90 | 18.24 | 17.15 | 4.52 | 3.88 | 1.41 | |
| PE Ratio | 18.17 | 29.55 | 20.51 | - | - | - | |
| Forward PE | 11.69 | 22.24 | 25.28 | 36.16 | - | - | |
| PS Ratio | 4.96 | 8.51 | 9.51 | 3.96 | 5.56 | 3.41 | |
| PB Ratio | 5.43 | 9.10 | 11.62 | 7.55 | 5.64 | 1.96 | |
| P/TBV Ratio | 5.35 | 9.18 | 11.75 | 7.79 | 5.81 | 2.03 | |
| P/FCF Ratio | 91.02 | 156.04 | 36.71 | 253.51 | - | - | |
| P/OCF Ratio | 50.25 | 86.14 | 34.16 | 116.07 | - | - | |
| EV/Sales Ratio | 4.95 | 8.55 | 9.56 | 4.26 | 6.33 | 4.24 | |
| EV/EBITDA Ratio | 12.65 | 21.86 | 27.74 | 35.88 | - | - | |
| EV/EBIT Ratio | 13.19 | 22.79 | 29.35 | 49.27 | - | - | |
| EV/FCF Ratio | 90.74 | 156.82 | 36.93 | 273.07 | - | - | |
| Debt / Equity Ratio | 0.17 | 0.17 | 0.24 | 1.05 | 1.02 | 0.73 | |
| Debt / EBITDA Ratio | 0.40 | 0.40 | 0.55 | 4.28 | - | - | |
| Debt / FCF Ratio | 2.87 | 2.87 | 0.74 | 35.10 | - | - | |
| Net Debt / Equity Ratio | -0.02 | -0.02 | -0.06 | 0.67 | 0.45 | 0.37 | |
| Net Debt / EBITDA Ratio | -0.04 | -0.04 | -0.14 | 2.94 | -2.11 | -0.99 | |
| Net Debt / FCF Ratio | -0.28 | -0.28 | -0.19 | 22.35 | -0.92 | -0.41 | |
| Asset Turnover | 0.92 | 0.92 | 1.04 | 0.76 | 0.49 | 0.34 | |
| Inventory Turnover | 1.15 | 1.15 | 1.21 | 1.01 | 0.83 | 0.77 | |
| Quick Ratio | 3.54 | 3.54 | 2.76 | 1.58 | 2.60 | 2.62 | |
| Current Ratio | 6.71 | 6.71 | 5.97 | 5.16 | 6.89 | 6.87 | |
| Return on Equity (ROE) | 35.56% | 35.56% | 81.64% | -19.67% | -44.96% | -62.46% | |
| Return on Assets (ROA) | 21.50% | 21.50% | 21.24% | 4.12% | -7.88% | -14.87% | |
| Return on Invested Capital (ROIC) | 33.39% | 38.62% | 50.24% | 10.03% | -19.07% | -35.65% | |
| Return on Capital Employed (ROCE) | 34.50% | 34.50% | 32.10% | 8.00% | -12.70% | -23.40% | |
| Earnings Yield | 5.80% | 3.38% | 4.88% | -2.77% | -7.69% | -25.95% | |
| FCF Yield | 1.10% | 0.64% | 2.72% | 0.39% | -8.57% | -45.59% | |
| Buyback Yield / Dilution | -5.07% | -5.07% | -4.07% | -13.19% | -41.77% | -62.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.